Cost-Utility Analysis Of Dimethyl Fumarate Versus Fingolimod And Teriflunomide In Patients With Relapsing-Remitting Multiple Sclerosis In Colombia
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.506
https://www.valueinhealthjournal.com/article/S1098-3015(16)31873-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
478
First Page :
A434
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31873-3&doi=10.1016/j.jval.2016.09.506